Although there has been some progress in pharmacological management of PAH, limited functional capacity and low survival still persist, but there is evidence that exercise training can be accomplished without adverse effects or damage to cardiac function and pulmonary hemodynamics. Specifically, improvements in symptoms, exercise capacity, peripheral muscle function and quality of life. Training programs need to be better studied and well defined, and their physiological effects during physical training and functional capacity. The aim of this study is to compare the effects of different training exercises on physical performance indicators.
Pulmonary arterial hypertension (PAH) is characterized by pathological changes in the pulmonary vasculature which cause an increase in pulmonary vascular resistance (PVR), restricting the flow of blood through the pulmonary circulation. It is a serious illness, progressive and usually fatal which causes significant functional limitation, mainly due to dyspnea. In order to maintain the flow of blood, pulmonary artery pressure (PAP) increases and the disease progresses leading to right ventricular dysfunction and right heart failure. Regardless of the cause of PAH, the pulmonary arteries and arterioles have reduced capacity, and increases in cardiac output during exercise is limited. As a result, the delivery of oxygen to peripheral muscles is impaired, contributing to the symptoms of fatigue and dyspnea. While the limitation of the cardiac output to meet peripheral oxygen demand during exercise largely reduces exercise capacity, musculoskeletal dysfunction may also be involved in the exercise limitation in patients with PAH. Changes such as, muscle atrophy, decreased oxidative enzymes and a greater number of type II muscle fibers lead to an early lactic acidosis and decreased functional capacity. A modest evidence exists that exercise training can be done without adverse effects or damage to cardiac and / or pulmonary hemodynamics however, the effectiveness PAH requires more research.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
45
Effects of different physical activity programs
Santa Casa de São Paulo Hospital
São Paulo, São Paulo, Brazil
RECRUITINGFunctional exercise capacity
Oxygen consumption measurement during cardiopulmonary test
Time frame: Change from Baseline to 15 weeks
6 Minute Walking Test
Distance in meters
Time frame: Change from Baseline to 15 weeks
Incremental shuttle walking test
Distance in meters
Time frame: Change from Baseline to 15 weeks
Autonomic Nervous System
Assesment by Heat Rate Variability analysis
Time frame: Change from Baseline to 15 weeks
Respiratory Muscle Strength
Assesment by Test of Incremental Respiratory Endurance
Time frame: Change from Baseline to 15 weeks
Musculoskeletal Function
Assesment by peripheral muscular strength testing.
Time frame: Change from Baseline to 15 weeks
Change of laboratory parameters, metabolic profile assessment and systemic inflammatory.
IL-1beta, IL-1ra, IL-6, IL-8, IL-10 and TNF-alfa (pg/ml)
Time frame: Change from Baseline to 15 weeks
Exhaled Nitric Oxide
The fraction of eNO (exhaled nitric oxide) in air will be measured by chemiluminescence
Time frame: Change from Baseline to 15 weeks
Lung function (physiological parameter)
Forced vital capacity and liters in 1 second, Total lung capacity, diffusion of carbon dioxide
Time frame: Change from Baseline to 15 weeks
Physical Activity Questionnaire (IPAQ)
The level of physical activity will be assessed using the international questionnaire short-version physical activity (IPAQ). The continuous score allows assessing energy expenditure expressed in MET minutes/week. The IPAQ categorical classifies include: Insufficiently active (does not perform any physical activity); Sufficiently active (conducts vigorous activity at least three days a week \>600 MET - 1400 MET); Very active (performs more than three days per week of vigorous activity 1500 MET - 3000 MET)
Time frame: Change from Baseline to 15 weeks
Endothelial function
Endothelial function will be assessed by flow-mediated dilation (FMD)
Time frame: Change from Baseline to 15 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.